Targeting PML-RARα and oncogenic signaling pathways by Chinese herbal mixture Tien-Hsien liquid in acute promyelocytic leukemia NB4 cells

Evidence-based Complementary and Alternative Medicine

Volumn 2011, Issue , 2011, Pages

  Lai, Tung Yuan ^e,f   Yao, Chih Jung ^a   Yang, Chia Ming ^b   Chuang, Shuang En ^c   Yan, Jiann Long ^c   Liu, Chun Yen ^b   Chen, Suz Wen ^c   Yan, Kun Huang ^c,d   Lai, Gi Ming ^a,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b Formosa Cancer Foundation   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID ETHYL ESTER; ARSENIC TRIOXIDE; CASPASE 3; CYCLIN A; CYCLIN B1; DNA METHYLTRANSFERASE 1; HERBACEOUS AGENT; HYBRID PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN KINASE B; SILICA GEL; TIEN HSIEN LIQUID; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CHINESE MEDICINE; CONTROLLED STUDY; DRUG EFFECT; GEL CHROMATOGRAPHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN BLOOD LEVEL; SIGNAL TRANSDUCTION;

EID: 79953283135     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nep165     Document Type: Article

References (51)

1. Sun A., Chia J.-S., Wang W.-B., Chiang C.-P., Immunomodulating effects of "Tien-Hsien liquid" on peripheral blood mononuclear cells and T-lymphocytes from patients with recurrent aphthous ulcerations American Journal of Chinese Medicine 2004 32 2 221 234 (Pubitemid 39011016)
2. Sun A., Chia J. S., Chiang C. P., Hsuen S. P., Du J. L., Wu C. W., The Chinese herbal medicine Tien-Hsien liquid inhibits cell growth and induces apoptosis in a wide variety of human cancer cells Journal of Alternative and Complementary Medicine 2005 11 245 256 (Pubitemid 40647159)
3. Chen G.-Q., Zhu J., Shi X.-G., Ni J.-H., Zhong H.-J., Si G.-Y., Jin X.-L., Tang W., Li X.-S., Xong S.-M., Shen Z.-X., Sun G.-L., Ma J., Zhang P., Zhang T.-D., Gazin C., Naoe T., Chen S.-J., Wang Z.-Y., Chen Z., In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML- RAR /PML proteins Blood 1996 88 3 1052 1061 (Pubitemid 26333331)
4. Zhang T.-D., Chen G.-Q., Wang Z.-G., Wang Z.-Y., Chen S.-J., Chen Z., Arsenic trioxide, a therapeutic agent for APL Oncogene 2001 20 49 7146 7153 (Pubitemid 33105004)
5. Senderowicz A. M., The cell cycle as a target for cancer therapy: basic and clinical findings with the small molecule inhibitors flavopiridol and UCN-01 Oncologist 2002 7 3 12 19
6. Stewart Z. A., Pietenpol J. A., Cell Cycle Checkpoints as Therapeutic Targets Journal of Mammary Gland Biology and Neoplasia 1999 4 4 389 400
7. Cai X., Yu Y., Huang Y., Zhang L., Jia P.-M., Zhao Q., Chen Z., Tong J.-H., Dai W., Chen G.-Q., Arsenic trioxide-induced mitotic arrest and apoptosis in acute promyelocytic leukemia cells Leukemia 2003 17 7 1333 1337 (Pubitemid 36857340)
8. Villa R., Morey L., Raker V. A., Buschbeck M., Gutierrez A., De Santis F., Corsaro M., Varas F., Bossi D., Minucci S., Pelicci P. G., Di Croce L., The methyl-CpG binding protein MBD1 is required for PML-RAR function Proceedings of the National Academy of Sciences of the United States of America 2006 103 5 1400 1405 (Pubitemid 43191177)
9. Mizuno S.-I., Chijiwa T., Okamura T., Akashi K., Fukumaki Y., Niho Y., Sasaki H., Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia Blood 2001 97 5 1172 1179 (Pubitemid 32183737)
10. Chen G. Q., Shi X. G., Tang W., Xiong S. M., Zhu J., Cai X., Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells Blood 1997 89 3345 2253
11. Zhu J., Lallemand-Breitenbach V., De Th H., Pathways of retinoic acid- or arsenic trioxide-induced PML/RAR catabolism, role of oncogene degradation in disease remission Oncogene 2001 20 49 7257 7265 (Pubitemid 33107375)
12. Cui X., Wakai T., Shirai Y., Yokoyama N., Hatakeyama K., Hirano S., Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells Human Pathology 2006 37 3 298 311 (Pubitemid 43277518)
13. Fazi F., Travaglini L., Carotti D., Palitti F., Diverio D., Alcalay M., McNamara S., Miller W. H. Jr., Lo Coco F., Pelicci P. G., Nervi C., Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivo Oncogene 2005 24 11 1820 1830 (Pubitemid 40462785)
14. Robert M.-F., Morin S., Beaulieu N., Gauthier F., Chute I. C., Barsalou A., MacLeod A. R., DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells Nature Genetics 2003 33 1 61 65 (Pubitemid 36068683)
15. McCubrey J. A., Steelman L. S., Abrams S. L., Bertrand F. E., Ludwig D. E., Bsecke J., Libra M., Stivala F., Milella M., Tafuri A., Lunghi P., Bonati A., Martelli A. M., Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy Leukemia 2008 22 4 708 722 (Pubitemid 351565619)
16. Steelman L. S., Abrams S. L., Whelan J., Bertrand F. E., Ludwig D. E., Bsecke J., Libra M., Stivala F., Milella M., Tafuri A., Lunghi P., Bonati A., Martelli A. M., McCubrey J. A., Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia Leukemia 2008 22 4 686 707 (Pubitemid 351565618)
17. Clemens D. L., Calisto L. E., Sorrell M. F., Tuma D. J., Ethanol metabolism results in a G2/M cell-cycle arrest in recombinant Hep G2 cells Hepatology 2003 38 2 385 393 (Pubitemid 36919859)
18. Hsieh W.-T., Huang K.-Y., Lin H.-Y., Chung J.-G., Physalis angulata induced G2/M phase arrest in human breast cancer cells Food and Chemical Toxicology 2006 44 7 974 983 (Pubitemid 43850066)
19. Kawasaki A., Matsumura I., Kataoka Y., Takigawa E., Nakajima K., Kanakura Y., Opposing effects of PML and PML/RAR on STAT3 activity Blood 2003 101 9 3668 3673 (Pubitemid 36857957)
20. Lunghi P., Tabilio A., Dall'Aglio P. P., Ridolo E., Carlo-Stella C., Pelicci P. G., Bonati A., Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts Leukemia 2003 17 9 1783 1793 (Pubitemid 37185254)
21. Martelli A. M., Nykern M., Tabellini G., Bortul R., Tazzari P. L., Evangelisti C., Cocco L., Phosphoinositide 3-kinase/ Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia Leukemia 2006 20 6 911 928 (Pubitemid 43797279)
22. Rcher C., Dos Santos C., Demur C., Payrastre B., mTOR, a new therapeutic target in acute myeloid leukemia Cell Cycle 2005 4 11 1538 1547 (Pubitemid 41609135)
23. Chow S., Minden M. D., Hedley D. W., Constitutive phosphorylation of the S6 ribosomal protein via mTOR and ERK signaling in the peripheral blasts of acute leukemia patients Experimental Hematology 2006 34 9 1182 1190 (Pubitemid 44291495)
24. Dos Santos C., Rcher C., Demur C., Payrastre B., The PI3K/Akt/mTOR pathway: a new therapeutic target in the treatment of acute myeloid leukemia Bulletin du Cancer 2006 93 5 445 447 (Pubitemid 43965764)
25. Smits V. A. J., Klompmaker R., Vallenius T., Rijksen G., Mkel T. P., Medema R. H., p21 Inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint Journal of Biological Chemistry 2000 275 39 30638 30643
26. Carnero A., Targeting the cell cycle for cancer therapy British Journal of Cancer 2002 87 2 129 133
27. Ling Y.-H., Consoli U., Tornos C., Andreeff M., Perez-Soler R., Accumulation of cyclin B1, activation of cyclin B1-dependent kinase and induction of programmed cell death in human epidermoid carcinoma KB cells treated with taxol International Journal of Cancer 1998 75 6 925 932 (Pubitemid 28134119)
28. Sleiman R. J., Stewart B. W., Early caspase activation in leukemic cells subject to etoposide-induced G2-M arrest: evidence of commitment to apoptosis rather than mitotic cell death Clinical Cancer Research 2000 6 3756 3765
29. Ling Y.-H., Jiang J.-D., Holland J. F., Perez-Soler R., Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines Molecular Pharmacology 2002 62 3 529 538 (Pubitemid 36329371)
30. Seol J. G., Park W. H., Kim E. S., Jung C. W., Hyun J. M., Kim B. K., Lee Y. Y., Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1 Biochemical and Biophysical Research Communications 1999 265 2 400 404
31. Li X. K., Motwani M., Tong W., Bornmann W., Schwartz G. K., Huanglian, A Chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells Molecular Pharmacology 2000 58 1287 1293
32. Prasad S., Kaur J., Roy P., Kalra N., Shukla Y., Theaflavins induce G2/M arrest by modulating expression of p21waf1/cip1, cdc25C and cyclin B in human prostate carcinoma PC-3 cells Life Sciences 2007 81 17-18 1323 1331 (Pubitemid 47599530)
33. Choi Y. H., Zhang L., Lee W. H., Park K.-Y., Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells International Journal of Oncology 1998 13 2 391 396 (Pubitemid 28329231)
34. Visanji J. M., Thompson D. G., Padfield P. J., Induction of G2/M phase cell cycle arrest by carnosol and carnosic acid is associated with alteration of cyclin A and cyclin B1 levels Cancer Letters 2006 237 1 130 136 (Pubitemid 44262316)
35. Nason-Burchenal K., Takle G., Pace U., Flynn S., Allopenna J., Martin P., Targeting the PML/RAR alpha translocation product triggers apoptosis in promyelocytic leukemia cells Oncogene 1998 17 1759 1768 (Pubitemid 28482778)
36. Di Croce L., Raker V. A., Corsaro M., Fazi F., Fanelli M., Faretta M., Fuks F., Lo Coco F., Kouzarides T., Nervi C., Minucci S., Pelicci P. G., Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor Science 2002 295 5557 1079 1082 (Pubitemid 34132239)
37. Agoston A. T., Argani P., Yegnasubramanian S., De Marzo A. M., Ansari-Lari M. A., Hicks J. L., Davidson N. E., Nelson W. G., Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer Journal of Biological Chemistry 2005 280 18 18302 18310 (Pubitemid 41389076)
38. Etoh T., Kanai Y., Ushijima S., Nakagawa T., Nakanishi Y., Sasako M., Kitano S., Hirohashi S., Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers American Journal of Pathology 2004 164 2 689 699 (Pubitemid 38364682)
39. McCabe M. T., Davis J. N., Day M. L., Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway Cancer Research 2005 65 9 3624 3632 (Pubitemid 40616339)
40. Nakagawa T., Kanai Y., Ushijima S., Kitamura T., Kakizoe T., Hirohashi S., DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis The Journal of Urology 2005 173 1767 1771 (Pubitemid 40524829)
41. Peng D.-F., Kanai Y., Sawada M., Ushijima S., Hiraoka N., Kosuge T., Hirohashi S., Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas Cancer Science 2005 96 7 403 408 (Pubitemid 41179741)
42. Sawada M., Kanai Y., Arai E., Ushijima S., Ojima H., Hirohashi S., Increased expression of DNA methyltransferase 1 (DNMT1) protein in uterine cervix squamous cell carcinoma and its precursor lesion Cancer Letters 2007 251 2 211 219 (Pubitemid 46669793)
43. Kassis E. S., Zhao M., Hong J. A., Chen G. A., Nguyen D. M., Schrump D. S., Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells Journal of Thoracic and Cardiovascular Surgery 2006 131 2, article no. e2 298 306
44. Zhang S., Zeng F., Peng S., Zhu C., Li H., Wang L., Effects on biological behavior of bladder carcinoma T24 cells via silencing DNMT1 and/or DNMT3b with shRNA in vitro Journal of Huazhong University of Science and Technology 2009 29 215 219
45. Bhalla K. N., Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies Journal of Clinical Oncology 2005 23 17 3971 3993 (Pubitemid 46218700)
46. Hwan S. C., Jong H. P., Kim Y.-J., Epigenomics: novel aspect of genomic regulation Journal of Biochemistry and Molecular Biology 2007 40 2 151 155 (Pubitemid 46515192)
47. Jung Y., Park J., Kim T. Y., Park J.-H., Jong H.-S., Im S.-A., Robertson K. D., Bang Y.-J., Kim T.-Y., Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy Journal of Molecular Medicine 2007 85 10 1137 1148 (Pubitemid 47476731)
48. Reid G. K., Besterman J. M., MacLeod A. R., Selective inhibition of DNA methyltransferase enzymes as a novel strategy for cancer treatment Current Opinion in Molecular Therapeutics 2002 4 2 130 137 (Pubitemid 34649804)
49. Dong S., Chen S.-J., Tweardy D. J., Cross-talk between retinoic acid and stat3 signaling pathways in acute promyelocytic leukemia Leukemia and Lymphoma 2003 44 12 2023 2029 (Pubitemid 37369641)
50. Bonati A., Rizzoli V., Lunghi P., Arsenic trioxide in hematological malignancies: the new discovery of an ancient drug Current Pharmaceutical Biotechnology 2006 7 6 397 405 (Pubitemid 46017530)
51. Lunghi P., Tabilio A., Lo-Coco F., Pelicci P. G., Bonati A., Arsenic trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells Leukemia 2005 19 234 244 (Pubitemid 40220588)